John Theurer Cancer Center expands to HOPE Tower

What you need to know

John Theurer Cancer Center, part of the NCI-designated Georgetown Lombardi Comprehensive Cancer Center, is expanding to HOPE Tower at Jersey Shore University Medical Center.

John Theurer Cancer Center at HOPE Tower now provides leukemia and adult blood and marrow stem cell transplantation services. 

It will also be one of the few sites offering CAR-T cell therapy in lymphoma, leukemia and myeloma. JTCC has been involved in CAR-T cell therapies for almost a decade. 

The site offers comprehensive medical and surgical oncology/hematology consultative services by national experts for all types and stages of cancer and serious blood disorders. The facility provides full infusion services, genomics analysis, and access to cutting-edge clinical trials.

All care will be provided in accordance with John Theurer quality standards and protocols. Internationally renowned researchers from the center will conduct specialty clinics at the location. 

About John Theurer Cancer Center

John Theurer Cancer Center at Hackensack University Medical Center is ranked as the best cancer center in New Jersey by U.S. News & World Report. The premier cancer center is best known for having a nationally recognized blood cancers program including multiple myeloma, lymphoma and leukemia, as well as having one of the largest nationwide Bone Marrow Transplant (BMT) programs. The new location will give patients in southern New Jersey as well as central New Jersey and the surrounding states of Philadelphia and Delaware, access to expertise, clinical trials and research.